INOV8 Surgical Performs 1st Surgery using THINK Surgical’s Next-Generation Robot Technology for Knee Replacement

THINK Surgical, Inc., an innovator in the field of orthopedic active robot surgery, is pleased to announce that INOV8 Surgical is the first healthcare facility to utilize the second-generation TSolution One® Total Knee Application for total knee arthroplasty (TKA). Stefan Kreuzer, M.D., orthopedic surgeon, and the founder of INOV8 Orthopedics, performed the first procedure with the new system on August 24th at INOV8 Surgical Ambulatory Surgery Center (ASC) in Houston, Texas.

THINK’s TSolution One system is the only robot system for TKA that supports an open implant library, giving surgeons the largest choice of implant options from different manufactures facilitating broad patient customization.

“My team and I are pleased to offer our patients the accuracy and reproducibility made possible in joint replacement procedures by THINK Surgical’s next-generation active robot,” said Dr. Kreuzer*. “Adoption of this advanced technology demonstrates our commitment to deliver exceptional outcomes for our patients.”

Dr. Kreuzer incorporated the first-generation TSolution One system into the INOV8 Surgical orthopedics program in early 2020, shortly after initial FDA clearance. INOV8 Surgical is a leading healthcare facility specializing in outpatient total joint procedures.

“We are very excited to have our latest robotic technology available to patients through the INOV8 Surgical ASC,” said Jay Yang, acting CEO and COO of THINK Surgical, Inc. “Our innovative engineers continue to advance robotic orthopedic surgery as demonstrated by our next-generation system and by future product launches.”

The TSolution One system consists of TPLAN®, a 3D pre-surgical planning workstation, and TCAT®, an active robot. Pre-surgical planning allows the surgeon to design and prepare the patient’s personalized joint replacement surgical plan in a virtual environment. The active robot aids the surgeon in executing the preoperative surgical plan with precise, automated cutting and removal of the diseased bone and cartilage. The TSolution One system assists surgeons with optimizing joint implant placement based on each patient’s unique anatomy.

The first full commercial launch was announced in 2020.

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."